Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
34.18%EBIT Margin
VS
Market
Sector
Industry
History
$ 3.2Close
$ 0.43 - $ 3.45 52-Week Range
Ticker Information
Ticker
CTMXCompany Name
CYTOMX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCYTOMX THERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CTMX - EBIT % Historical data
| Date | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 48.23M | 34.18% | $ 141.1M |
| 3/31/2025 | $ 41.84M | 28.35% | $ 147.56M |
| 12/31/2024 | $ 32.09M | 23.24% | $ 138.1M |
| 9/30/2024 | $ 15.06M | 11.89% | $ 126.62M |
| 6/30/2024 | $ 15.08M | 12.61% | $ 119.57M |
| 3/31/2024 | $ 20.47M | 17.18% | $ 119.18M |
| 12/31/2023 | $ 3.32M | 3.28% | $ 101.21M |
| 9/30/2023 | $ -26.54M | -35.12% | $ 75.55M |
| 6/30/2023 | $ -55.65M | -84.2% | $ 66.08M |
| 3/31/2023 | $ -78.74M | -132.29% | $ 59.52M |
Key Performance Insights, Last 5 Years
- CYTOMX THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at -73.67%.
- Over the past 5 years, CYTOMX THERAPEUTICS INC's average EBIT % has been -62.18%.
- The median EBIT % for CYTOMX THERAPEUTICS INC during this period was -78.94%
- CYTOMX THERAPEUTICS INC reached its highest EBIT % over the past 5 years at 34.18%.
- The lowest EBIT % recorded by CYTOMX THERAPEUTICS INC in the same timeframe -186.82%
CYTOMX THERAPEUTICS INC's EBIT % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT % Benchmarks
Similar metrics to Revenues:
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
Definition of EBIT Margin
[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.EBIT / Revenues
(=) EBIT % EBIT % for CYTOMX THERAPEUTICS INC is calculated as follows: EBIT [ $ -67.97M ] / Revenues [ $ 92.27M ]
(=) EBIT % [ -73.67% ] CTMX - EBIT Margin, Last 5 years
-186.82%
Minimum
Dec 31, 2022
34.18%
Maximum
Jun 30, 2025
-62.18%
Average
-78.94%
Median
EBIT % Benchmark AnalysisMarket
The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
| filtered constituents | 3.26K |
|---|---|
| min | -73.16% |
| max | 83.08% |
| average | 9.54% |
| median | 9.01% |
| std | 23.96% |